Product portfolio

Our products are all high-quality, affordable medicines, supported by a dedicated patent portfolio, guaranteeing a long product lifespan. In the portfolio below, you can find our products by name, therapeutic area or indication.


Allergy
Levocetirizine
Urticaria/allergic rhinitis
tab 5 mg
Montelukast
Asthma/allergy
chewable 4/5 mg
Montelukast
Asthma/allergy
tab 10 mg
Anti-infective
Linezolid
Anti-infective
inf bag 2 mg/ml 300 ml
Linezolid
Anti-infective
tab 600 mg
Voriconazole
Anti-fungal
tab 50/200 mg
Voriconazole
Anti-fungal
lyo 200 mg/vial
Cardiovascular
Anagrelide
Thrombocythemia
cap 0.5/1 mg
Bisoprolol
Hypertension
tab 5/10 mg
Bisoprolol HCT
Hypertension
tab 5+12.5/10+25 mg
Dobutamine
Heart failure
inj 12.5 mg/ml - 20 ml
Doxazosin
Hypertension/benign prostatic hyperplasia
tab 2/4/8 mg
Eplerenone
Congestive heart failure
tab 25/50 mg
Ivabradine
Angina pectoris
tab 2.5/5/7.5 mg
Simvastatin
Hypercholesterolemia
tab 5/10/20/40/80 mg
Central Nervous System
Aripiprazole
Schizophrenia
tab 5/10/15/20/30 mg
Aripiprazole
Schizophrenia
odt 10/15 mg
Clozapine
Schizophrenia
tab 25/100 mg
Donepezil
Alzheimer
tab 5/10 mg
Escitalopram
Depression
tab 10/15/20 mg
Fluvoxamine
Depression
tab 50/100 mg
Glatiramer
Relapsing remitting multiple sclerosis
syringe 20 mg/ml
Memantine
Alzheimer
tab 5/10/15/20 mg
Paroxetine
Depression
tab 20 mg
Paroxetine
Depression
drops 20 mg/20 drops - 20 ml flask
Pramipexole
Parkinson/restless leg syndrome
tab 0.125/0.25/0.5/1.0/1.5 mg
Propofol (LCT)
Anesthesia
inj 1%: 20/50/100 ml; inj 2%: 50 ml
Rasagiline
Parkinson
tab 1 mg
Zolpidem
Insomnia
tab 5/10 mg
Zopiclone
Insomnia
tab 3.75/5/7.5 mg
Musculoskeletal system
Celecoxib
Arthritis
cap 100/200 mg
Etoricoxib
Inflammation
tab 30/60/90/120 mg
Ibandronate
Osteoporosis
syringe 3 mg/3 ml
Ibandronate
Osteoporosis
tab 150 mg
Raloxifene
Osteoporosis
tab 60 mg
Zoledronic acid
Paget's disease
inf bag 5 mg/100 ml
Oncology
Anastrozole
Breast cancer
tab 1 mg
Bendamustine
Chronic lymphocytic leukemia
lyo 25/100 mg/vial
Bicalutamide
Prostate cancer
tab 50/150 mg
Bortezomib
Multiple myeloma
lyo 1/3.5 mg/vial
Exemestane
Breast cancer
tab 25 mg
Ibandronate
Bone metastases
vial 2 mg/2 ml, 6 mg/6 ml
Ibandronate
Bone metastases
tab 50 mg
Imatinib
Chronic myeloid leukemia
cap 100 mg
Imatinib
Chronic myeloid leukemia
tab 100/400 mg
Letrozole
Breast cancer
tab 2.5 mg
Pemetrexed
Lung cancer
lyo 100/500/1000 mg/vial
Zoledronic acid
Bone metastases
vial 4 mg/5 ml
Systemic
Cinacalcet
Hyperparathyroidism
tab 30/60/90 mg
Urology
Doxazosin
Hypertension/benign prostatic hyperplasia
tab 2/4/8 mg
Sevelamer
Chronic kidney failure
sachet 2.4 g
Sevelamer
Chronic kidney failure
tab 800 mg
Tamsulosin
Benign prostatic hyperplasia
mr tab 0.4 mg
Tamsulosin
Benign prostatic hyperplasia
mr cap 0.4 mg

Note

Please note that the reference date for this product list is April 2017. Our portfolio of approved products differs from country to country. In addition to the commercial products mentioned above, Synthon owns a rich pipeline of research projects and pending regulatory applications for multiple products.

This webpage contains information on pharmaceutical products and has been composed for healthcare professionals.

Adverse events

If you experience any side effects associated with a Synthon product, we need to get in touch with you for further information. Please contact us to report an adverse event related to Synthon products by sending us an e-mail.

report adverse event